The global transdermal drug delivery systems market size reached US$ 6.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2027, exhibiting a growth rate (CAGR) of 6.36% during 2022-2027. The increasing prevalence of chronic, cardiovascular, and central nervous system disorders and the rising need for self-administration drug delivery systems are majorly driving the transdermal drug delivery systems market growth.
Market Outlook:
Transdermal drug delivery systems (TDDS) are self-contained dosages that administer biological active agents and cosmeceuticals through the patient’s skin at a predetermined amount. They use appendageal, transcellular, and intercellular as three main routes for drug penetration. TDDS offer painless delivery with prolonged therapeutic effects, improved bioavailability, even plasma levels, and lesser side effects.
Consequently, TDDS are utilized as an effective alternative to subcutaneous, oral intravascular, and transmucosal routes for pain management and treatment of various ailments. At present, TDDS mainly include scopolamine, nicotine, nitro-glycerine, and lidocaine as standard drugs.
Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.
Request to get the sample report: https://www.imarcgroup.com/transdermal-drug-delivery-systems-market/requestsample
Market Trends:
The widespread adoption of transdermal patches across the healthcare sector to treat diabetes is supplementing the product demand in the market. Moreover, growing awareness amongst patients regarding various benefits of transdermal patches, such as enhanced convenience and bioavailability with reduced dosing frequency and adverse effects, is favoring the market growth.
Additionally, the advent of mHealth and homecare settings and the shifting preference toward transdermal drug delivery, due to their heightened drug diffusion capabilities and pain-free medication administration, are creating a positive outlook for the market. Besides this, the large-scale integration of microneedles or mechanical arrays, pressure-sensitive adhesives, and permeation enhancers in transdermal patches and ongoing research and development (R&D) activities are positively stimulating the market growth.
Transdermal Drug Delivery Systems Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the global transdermal drug delivery systems market has been studied in the report with the detailed profiles of the key players operating in the market.
List of Key Companies Covered in this Market Report:
- 3M Company (NYSE: MMM)
- Acrux Limited (OTCMKTS: ARUXF)
- Boehringer Ingelheim International GmbH
- Hisamitsu Pharmaceutical Co. Inc. (TYO: 4530)
- Lavipharm S.A. (FRA: BXA0)
- LEAD CHEMICAL Co. Ltd.
- Luye Pharma Group (HKG: 2186)
- Nutriband Inc. (NASDAQ: NTRB)
- Viatris Inc. (NASDAQ: VTRS)
Market Segmentation:
The report has segmented the global transdermal drug delivery systems market on the basis of technology, application and region.
Based on Technology:
- Electroporation
- Radiofrequency
- Iontophoresis
- Microporation
- Thermal
- Mechanical Arrays
- Ultrasound
- Others
Based on Application:
- Central Nervous System
- Pain Management
- Cardiovascular
- Hormone
- Others
Geographical Analysis:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Make inquiry before purchase of this report: https://www.imarcgroup.com/request?type=report&id=3983&flag=F
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
Transdermal Drug Delivery Systems: IntroductionTransdermal is a route of administration, wherein drugs are administered through the skin to achieve systemic distributionRecent advancements in transdermal route of administration such as ultrasound waves, laser, and microneedle patches for efficient penetration of the dermis layer of the skin drive the global transdermal drug delivery systems marketRequest Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=158 Key Drivers and Restraints of Global Transdermal Drug Delivery Systems MarketDemand for novel techniques with low dose and less dosing frequency of drugs is increasing rapidly.
Patients being discharged from health care services such as hospitals and clinics still need observation.
Hence, both professional caregivers and laypersons are using several types of equipment or devices, some of these composite, in non-institutional settings to control personal health, support others, or take support of health organization.
These equipment offer support in several health conditions such as chronic and acute diseases and help in prevention of diseases.Demand for automated drug delivery systems has increased.
For instance, Logiq wireless solutions is a remotely controlled transdermal drug delivery device.
These factors are projected to drive the global transdermal drug delivery systems market.Request COVID Analysis on Transdermal Drug Delivery Systems Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=158 Diabetes Application Segment to Lead Global MarketThe global transdermal drug delivery systems market can be segmented based on application, end-user, and regionIn terms of application, the global transdermal drug delivery systems market can be divided into infectious diseases, oncology, ophthalmology, urology, diabetes, CNS, and others.
